0001607062-20-000293.txt : 20201103 0001607062-20-000293.hdr.sgml : 20201103 20200930160929 ACCESSION NUMBER: 0001607062-20-000293 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kannalife Inc CENTRAL INDEX KEY: 0001615999 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462645343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 858-883-2642 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 FORMER COMPANY: FORMER CONFORMED NAME: TYG Solutions Corp. DATE OF NAME CHANGE: 20140821 FORMER COMPANY: FORMER CONFORMED NAME: TYG Solutions Inc. DATE OF NAME CHANGE: 20140806 CORRESP 1 filename1.htm

Kannalife, Inc.

3805 Old Easton Road

Doylestown, PA 18902

 

 

September 30, 2020

VIA EDGAR

Division of Corporation Finance
Office of Life Sciences

U.S. Securities & Exchange Commission (the “Commission”)

100 F Street, N.E.

Washington, D.C. 20549

 

   
Attention: Margaret Schwartz
   
   
Re: Kannalife, Inc.
 

Registration Statement on Form S-1

Filed September 22, 2020

  File No. 333-248966

 

Ladies and Gentlemen:

        

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Kannalife, Inc. (the “Company”) hereby requests that the effective date for the above-referenced Registration Statement on Form S-1 (File No. 333-248966) be accelerated so that it will be declared effective at 4:30 PM Eastern Standard Time on October 2, 2020, or as soon thereafter as is practicable.

 

The undersigned, on behalf of the Company, acknowledges the following:

 

•should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

•the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

•the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States

 

  Sincerely,
   
  KANNALIFE, INC.
   
  /s/ Dean Petkanas
  Dean Petkanas
  Chief Executive Officer and Chairman